1.Glina S, Cohen DJ, Vieira M: Diagnosis of erectile dysfunction. Current opinion in psychiatry 2014, 27(6):394-399.
2.Rajkumar RP: The impact of disrupted childhood attachment on the presentation of psychogenic erectile dysfunction: an exploratory study. J Sex Med 2015, 12(3):798-803.
3.Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB: Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003, 139(3):161-168.
4.Capogrosso P, Montorsi F, Salonia A: Erectile dysfunction in young patients is a proxy of overall men's health status. Current opinion in urology 2016, 26(2):140-145.
5.Zusman RM: Cardiovascular data on sildenafil citrate: introduction. The American journal of cardiology 1999, 83(5a):1c-2c.
6.Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB: Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study. The Journal of Urology 1994, 151(1):54-61.
7.Vicenzini E, Altieri M, Michetti PM, Ricciardi MC, Ciccariello M, Shahabadi H, Puccinelli F, Lenzi GL, Di Piero V: Cerebral vasomotor reactivity is reduced in patients with erectile dysfunction. Eur Neurol 2008, 60(2):85-88.
8.Shamloul R, Ghanem H: Erectile dysfunction. Lancet 2013, 381(9861):153-165.
9.Yuan J, Zhang R, Yang Z, Lee J, Liu Y, Tian J, Qin X, Ren Z, Ding H, Chen Q et al: Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol 2013, 63(5):902-912.
10.Kim SC, Lee YS, Seo KK, Jung GW, Kim TH: Reasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patients. Int J Impot Res 2014, 26(3):87-93.
11.Gong B, Ma M, Xie W, Yang X, Huang Y, Sun T, Luo Y, Huang J: Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. Int Urol Nephrol 2017, 49(10):1731-1740.
12.Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E, European Association of U: Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010, 57(5):804-814.
13.Hatzichristou D, d'Anzeo G, Porst H, Buvat J, Henneges C, Rossi A, Hamidi K, Buttner H: Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities. BMC Urol 2015, 15:111.
14.Bai WJ, Li HJ, Dai YT, He XY, Huang YR, Liu JH, Sorsaburu S, Ji C, Jin JJ, Wang XF: An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naive to phosphodiesterase 5 inhibitor therapy. Asian J Androl 2015, 17(1):61-67.
15.Brock G, Ni X, Oelke M, Mulhall J, Rosenberg M, Seftel A, D'Souza D, Barry J: Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases. J Sex Med 2016, 13(5):860-875.
16.Buvat J, Buttner H, Hatzimouratidis K, Vendeira PA, Moncada I, Boehmer M, Henneges C, Boess FG: Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction. J Sex Med 2013, 10(6):1592-1602.
17.Andersson KE: Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev 2011, 63(4):811-859.
18.Francis SH, Busch JL, Corbin JD, Sibley D: cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 2010, 62(3):525-563.
19.Liu Q, Zhang P, Pan J, Li Z, Liu J, Li G, Qin W, You Y, Yu X, Sun J et al: Cerebral Activity Changes in Different Traditional Chinese Medicine Patterns of Psychogenic Erectile Dysfunction Patients. Evid Based Complement Alternat Med 2015, 2015:503536.
20.Cera N, Delli Pizzi S, Di Pierro ED, Gambi F, Tartaro A, Vicentini C, Paradiso Galatioto G, Romani GL, Ferretti A: Macrostructural alterations of subcortical grey matter in psychogenic erectile dysfunction. PLoS One 2012, 7(6):e39118.
21.Zhang P, Liu J, Li G, Pan J, Li Z, Liu Q, Qin W, Dong M, Sun J, Huang X et al: White matter microstructural changes in psychogenic erectile dysfunction patients. Andrology 2014, 2(3):379-385.
22.Arnow BA, Desmond JE, Banner LL, Glover GH, Solomon A, Polan ML, Lue TF, Atlas SW: Brain activation and sexual arousal in healthy, heterosexual males. Brain 2002, 125(Pt 5):1014-1023.
23.Chen J, Chen Y, Chen G, Dai Y, Yao Z, Lu Q: Altered brain networks in psychogenic erectile dysfunction: a resting-state fMRI study. Andrology 2017, 5(6):1073-1081.
24.Chen J, Chen Y, Gao Q, Chen G, Dai Y, Yao Z, Lu Q: Brain structural network topological alterations of the left prefrontal and limbic cortex in psychogenic erectile dysfunction. Int J Neurosci 2018, 128(5):393-403.
25.Chen J, Chen Y, Gao Q, Chen G, Dai Y, Yao Z, Lu Q: Impaired Prefrontal-Amygdala Pathway, Self-Reported Emotion, and Erection in Psychogenic Erectile Dysfunction Patients With Normal Nocturnal Erection. Front Hum Neurosci 2018, 12:157.
26.Oh SK, Kim GW, Yang JC, Kim SK, Kang HK, Jeong GW: Brain activation in response to visually evoked sexual arousal in male-to-female transsexuals: 3.0 tesla functional magnetic resonance imaging. Korean J Radiol 2012, 13(3):257-264.
27.Georgiadis JR, Farrell MJ, Boessen R, Denton DA, Gavrilescu M, Kortekaas R, Renken RJ, Hoogduin JM, Egan GF: Dynamic subcortical blood flow during male sexual activity with ecological validity: a perfusion fMRI study. NeuroImage 2010, 50(1):208-216.
28.Seo Y, Jeong B, Kim JW, Choi J: The relationship between age and brain response to visual erotic stimuli in healthy heterosexual males. Int J Impot Res 2010, 22(4):234-239.
29.Hayasaka S, Peiffer AM, Hugenschmidt CE, Laurienti PJ: Power and sample size calculation for neuroimaging studies by non-central random field theory. NeuroImage 2007, 37(3):721-730.
30.Desmond JE, Glover GH: Estimating sample size in functional MRI (fMRI) neuroimaging studies: statistical power analyses. J Neurosci Methods 2002, 118(2):115-128.
31.Chen L, Staubli SE, Schneider MP, Kessels AG, Ivic S, Bachmann LM, Kessler TM: Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis. Eur Urol 2015, 68(4):674-680.
32.Deng Y, Zhang CH, Zhang HN: [Effects of chaihu shugan powder on the behavior and expressions of BDNF and TrkB in the hippocampus, amygdala, and the frontal lobe in rat model of depression]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 2011, 31(10):1373-1378.
33.Kim SW, Sohn DW, Cho YH, Yang WS, Lee KU, Juh R, Ahn KJ, Chung YA, Han SI, Lee KH et al: Brain activation by visual erotic stimuli in healthy middle aged males. Int J Impot Res 2006, 18(5):452-457.
34.Gao M, Yang X, Liu L, Fei N, Xi Y, Guo F, Yan F, Meng P, Yu L, Liu P et al: Abnormal White Matter Microstructure in Lifelong Premature Ejaculation Patients Identified by Tract-Based Spatial Statistical Analysis. J Sex Med 2018, 15(9):1272-1279.
35.Rifbjerg-Madsen S, Christensen AW, Boesen M, Christensen R, Danneskiold-Samsoe B, Bliddal H, Dreyer L, Locht H, Amris K: The course of pain hypersensitivity according to painDETECT in patients with rheumatoid arthritis initiating treatment: results from the prospective FRAME-cohort study. Arthritis Res Ther 2018, 20(1):105.
36.Yin S, Chen Y, Lei D, Sun RR, Ma TT, Feng PM, He ZX, Suo XL, Ma PH, Qu YZ et al: Cerebral mechanism of puncturing at He-Mu point combination for functional dyspepsia: study protocol for a randomized controlled parallel trial. Neural regeneration research 2017, 12(5):831-840.
37.Petzke F, Jensen KB, Kosek E, Choy E, Carville S, Fransson P, Williams SCR, Marcus H, Mainguy Y, Ingvar M et al: Using fMRI to evaluate the effects of milnacipran on central pain processing in patients with fibromyalgia. Scandinavian journal of pain 2013, 4(2):65-74.
38.Koopmann A, Bach P, Schuster R, Bumb JM, Vollstadt-Klein S, Reinhard I, Rietschel M, Witt SH, Wiedemann K, Kiefer F: Ghrelin modulates mesolimbic reactivity to alcohol cues in alcohol-addicted subjects: a functional imaging study. Addict Biol 2018.
39.Lu XW, Guo H, Sun JR, Dong QL, Zhao FT, Liao XH, Zhang L, Zhang Y, Li WH, Li ZX et al: A shared effect of paroxetine treatment on gray matter volume in depressive patients with and without childhood maltreatment: A voxel-based morphometry study. CNS neuroscience & therapeutics 2018, 24(11):1073-1083.
40.Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA et al: SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013, 158(3):200-207.
41.Schulz KF, Altman DG, Moher D, Group C: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010, 8:18.
42.Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hrobjartsson A, Schulz KF, Parulekar WR et al: SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013, 346:e7586.
43.Bai WJ, Li HJ, Jin JJ, Xu WP, Sebastian S, Wang XF: A randomized clinical trial investigating treatment choice in Chinese men receiving sildenafil citrate and tadalafil for treating erectile dysfunction. Asian J Androl 2017, 19(4):500-504.
44.Buvat J, Hatzichristou D, Boess FG, Buttner H, Gehchan N, Henneges C, Porst H: Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study. Int J Clin Pract 2014, 68(9):1087-1099.
45.Rosen RC, Cappelleri JC, Gendrano N, 3rd: The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 2002, 14(4):226-244.
46.Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49(6):822-830.
47.Lowy M, Collins S, Bloch M, Gillman M, Lording D, Sutherland P, Wang H, Stecher V: Quality of erection questionnaire correlates: change in erection quality with erectile function, hardness, and psychosocial measures in men treated with sildenafil for erectile dysfunction. J Sex Med 2007, 4(1):83-92.
48.Porst H, Gilbert C, Collins S, Huang X, Symonds T, Stecher V, Hvidsten K: Development and validation of the quality of erection questionnaire. J Sex Med 2007, 4(2):372-381.
49.Hvidsten K, Carlsson M, Stecher VJ, Symonds T, Levinson I: Clinically meaningful improvement on the quality of erection questionnaire in men with erectile dysfunction. Int J Impot Res 2010, 22(1):45-50.
50.Mulhall JP, Goldstein I, Bushmakin AG, Cappelleri JC, Hvidsten K: Validation of the erection hardness score. J Sex Med 2007, 4(6):1626-1634.
51.Cappelleri JC, Althof SE, Siegel RL, Shpilsky A, Bell SS, Duttagupta S: Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction. Int J Impot Res 2004, 16(1):30-38.
52.Hamilton M: The assessment of anxiety states by rating. The British journal of medical psychology 1959, 32(1):50-55.
53.Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
54.Berntsen EM, Rasmussen IA, Samuelsen P, Xu J, Haraldseth O, Lagopoulos J, Malhi GS: Putting the brain in Jeopardy: a novel comprehensive and expressive language task?Acta neuropsychiatrica 2006, 18(2):115-119.
55.Hao H, Chen C, Mao W, Zhong J, Dai Z: Aberrant brain regional homogeneity in first-episode drug-naive patients with major depressive disorder: A voxel-wise meta-analysis. Journal of affective disorders 2018, 245:63-71.
56.Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM et al: Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 2006, 31(4):1487-1505.
57.Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE et al: Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004, 23 Suppl 1:S208-219.
58.Zhao N, Yuan LX, Jia XZ, Zhou XF, Deng XP, He HJ, Zhong J, Wang J, Zang YF: Intra- and Inter-Scanner Reliability of Voxel-Wise Whole-Brain Analytic Metrics for Resting State fMRI. Frontiers in neuroinformatics 2018, 12:54.
59.Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM et al: Erectile Dysfunction: AUA Guideline. J Urol 2018.
60.Li L, Fan W, Li J, Li Q, Wang J, Fan Y, Ye T, Guo J, Li S, Zhang Y et al: Abnormal brain structure as a potential biomarker for venous erectile dysfunction: evidence from multimodal MRI and machine learning. Eur Radiol 2018, 28(9):3789-3800.
61.Wang Y, Dong M, Guan M, Wu J, He Z, Zou Z, Chen X, Shi D, Liang J, Zhang X: Aberrant Insula-Centered Functional Connectivity in Psychogenic Erectile Dysfunction Patients: A Resting-State fMRI Study. Front Hum Neurosci 2017, 11:221.
62.Zhao L, Guan M, Zhang X, Karama S, Khundrakpam B, Wang M, Dong M, Qin W, Tian J, Evans AC et al: Structural insights into aberrant cortical morphometry and network organization in psychogenic erectile dysfunction. Hum Brain Mapp 2015, 36(11):4469-4482.
63.Zhao L, Guan M, Zhu X, Karama S, Khundrakpam B, Wang M, Dong M, Qin W, Tian J, Evans AC et al: Aberrant Topological Patterns of Structural Cortical Networks in Psychogenic Erectile Dysfunction. Front Hum Neurosci 2015, 9:675.